Zusammenfassung
Die Proktokolektomie und Anlage eines ileoanalen Pouches ist bei Patienten mit Colitis ulcerosa (CU) bzw. familiärer adenomatöser Polyposis (FAP), die einer operativen Therapie bedürfen, die Therapie der Wahl. Als häufigste postoperative Komplikation ist die idiopathische Pouchitis zu beobachten, die bei bis zu 50% der Patienten mit zugrunde liegender CU, aber nur bei 5% der Patienten mit FAP auftritt. Die klinischen Symptome der Erkrankung sind unspezifisch. Von der idiopathischen Pouchitis sind postoperative Komplikationen (Stenosen, Fisteln etc.) durch endoskopische Untersuchungen des Pouches und in einzelnen Fällen durch Endosonographie oder MRT des Beckens abzugrenzen. Zur Therapie der idiopathischen Pouchitis werden Antibiotika, üblicherweise Metronidazol oder Ciprofloxazin, eingesetzt. Probiotika wie VSL#3® können ein Wiederauftreten der Pouchitis verhindern. Insgesamt sind auch bei Langzeitbeobachtung über 20 Jahre der klinische Verlauf und die Funktionalität bei Pouch-Trägern als sehr gut zu bezeichnen.
Abstract:
Restorative proctocolectomy with an ileal pouch-anal anastomosis is the treatment of choice in patients with ulcerative colitis (UC) and familial adenomatous polyposis requiring surgical therapy. Pouchitis is the most frequent complication, occurring in up to 50% of patients with underlying UC. Clinical symptoms of the disease are non-specific. Moreover, surgical complications must be differentiated from idiopathic pouchitis using pouchoscopy, endoscopic ultrasound or MRI of the pelvis in certain cases. The therapy for idiopathic pouchitis, its etiology and pathophysiology being unclear, is based on antibiotic treatment, usually with metronidazole or ciprofloxacin. Probiotics such as VSL#3® can be used to prevent relapse. In summary, the clinical and functional outcomes are excellent and stable for 20 years after surgery.
Literatur
Campbell AP, Merrett MN, Kettlewell M et al. (1994) Expression of colonic antigens by goblet and columnar epithelial cells in ileal pouch mucosa: their association with inflammatory change and faecal stasis. J Clin Pathol 47: 834–838
Gionchetti P, Rizzello F, Venturi A et al. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305–309
Gionchetti P, Rizzello F, Helwig U et al. (2003) Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124: 1202–1209
Fazio VW, Ziv Y, Church JM et al. (1995) Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 222: 120–127
Hahnloser D, Pemberton JH, Wolff BG et al. (in press) Results at up to 20 years after ileal pouch-anal anstomosis for chronic ulcerative colitis. Br J Surg: Epub ahead of print
Häuser W, Dietz N, Steder-Neukamm U et al. (2004) Biopsychosocial determinants of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis. Inflamm Bowel Dis 10: 399–407
Heuschen UA, Autschbach F, Allemeyer EH et al. (2001) Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum 44: 487–499
Hurst RD, Molinari M, Chung TP et al. (1996) Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 131: 497–500
Kartheuser AH, Parc R, Penna CP et al. (1996) Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: a ten-year experience. Surgery 119: 615–623
Kroesen AJ, Stern J, Buhr HJ et al. (1995) Incontinence after ileo-anal pouch anastomosis-diagnostic criteria and therapeutic sequelae. Chirurg 66: 385–391
Kühbacher T, Schreiber S, Runkel N (1998) Pouchitis: pathophysiology and treatment. Int J Colorect Dis 13: 196–207
Kuisma J, Nuutinen H, Luukkonen P et al. (2001) Long term metabolic consequences of ileal pouch-anal anastomosis for ulcerative colitis. Am J Gastroenterol 96: 3110–3116
Lichtenstein GR, Cohen R, Yamashita B et al. (2006) Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis. J Clin Gastroenterol 40: 669–677
Mahadevan U, Sandborn WJ (2003) Diagnosis and management of pouchitis. Gastroenterology 124: 1636–1650
Meagher AP, Farouk R, Dozois RR et al. (1998) J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 85: 800–803
Rauh SM, Schoetz DJ Jr, Roberts PL et al. (1991) Pouchitis–is it a wastebasket diagnosis? Dis Colon Rectum 34: 685–689
Sambuelli A, Boerr L, Negreira S et al. (2002) Budesonide enema in pouchitis–a double-blind, double-dummy, controlled trial. Aliment Pharmacol Ther 16: 27–34
Sandborn WJ, Tremaine WJ, Batts KP et al. (1994) Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 69: 409–415
Schreiber S, Raedler A, Conn AF et al. (1992) Increased release of soluble interleukin-2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease. Gut 32: 236–241
Shen B, Achkar JP, Lashner BA et al. (2001) A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 7: 301–305
Shen B, Achkar JP, Lashner BA et al. (2002) Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 97: 972–977
Shen B (2003) Diagnosis and treatment ot patients wih pouchitis. Drugs 63: 453–461
Shen B, Achkar JP, Connor JT et al. (2003) Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 46: 748–753
Shen B, Lashner BA (2005) Pouchitis: a spectrum of diseases. Curr Gastroenterol Rep 7: 404–411
Shen B, Fazio VW, Remzi FH et al. (2006) Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol 4: 81–89
Stallmach A, Schäfer F, Hoffmann S et al. (1989) Increased state of activation of CD 4 positive T cells and elevated interferon γ production in pouchitis. Gut 43: 499–505
Stallmach A, Moser C, Hero-Gross R et al. (1999) Pattern of mucosal adaptation in acute and chronic pouchitis. Dis Colon Rectum 42: 1311–1317
Stange EF, Buhr HJ (2004) Pouchitis. Z Gastroenterol 42: 1029–1032
Svaninger G, Nordgren S, Oresland T et al. (1993) Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch. Scand J Gastroenterol 28: 695–700
Tiainen J, Matikainen M, Aitola P et al. (2001) Histological and macroscopic changes in the pelvic pouch: long-term follow up after restorative proctocolectomy for ulcerative colitis (UC). Colorectal Dis 3: 28–32
Ulrich A, Z’graggen K, Weitz J et al. (2005) Functional results of the colon J-pouch versus transverse coloplasty pouch in Heidelberg. Recent Results Cancer Res 165: 205–211
Veress B, Reinholt FP, Lindquist K et al. (1995) Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology 109: 1090–1097
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stallmach, A., Schmidt, C. Ileoanale Pouch-Operation. Internist 48, 606–612 (2007). https://doi.org/10.1007/s00108-007-1835-8
Issue Date:
DOI: https://doi.org/10.1007/s00108-007-1835-8